Flow Cytometry: A Novel Approach for Indirect Assessment of Protamine Deficiency by CMA3 Staining, Taking into Account the Presence of M540 or Apoptotic Bodies
Background Chromomycin A3 (CMA3) staining, either by the slide method or fluorescence microscopy, is widely used for indirect assessment of protamine deficiency in a semen sample. Flow cytometry is the most suitable tool to improve assessment accuracy, both in terms of statistical analysis and fo...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Royan Institute (ACECR), Tehran
2011-10-01
|
| Series: | International Journal of Fertility and Sterility |
| Subjects: | |
| Online Access: | http://www.ijfs.ir/article_45096_6f1f745f24924b7b83cf544b2525341a.pdf |
| _version_ | 1818280001719500800 |
|---|---|
| author | Zohreh Fathi Marziyeh Tavalaee Abbas Kiani Mohammad Reza Deemeh Mehrdad Modaresi Mohammad Hossein Nasr-Esfahani |
| author_facet | Zohreh Fathi Marziyeh Tavalaee Abbas Kiani Mohammad Reza Deemeh Mehrdad Modaresi Mohammad Hossein Nasr-Esfahani |
| author_sort | Zohreh Fathi |
| collection | DOAJ |
| description | Background Chromomycin A3 (CMA3) staining, either by the slide method or fluorescence microscopy, is widely used for indirect assessment of protamine deficiency in a semen sample. Flow cytometry is the most suitable tool to improve assessment accuracy, both in terms of statistical analysis and for prevention of observer variation. This study provides a simple procedure to account for merocyanine 540 (M540) or apoptotic bodies, which result in underestimation of the percentage of CMA3 positivity, by using propidium iodide (PI) staining. Therefore, this study aims to evaluate the percentage of CMA3 by PI staining to exclude M540 bodies that prevent underestimation of CMA3 staining. Materials and Methods This study is an experimental study. Semen samples collected from 104 infertile men who referred to the Andrology Unit of the Isfahan Fertility and Infertility Center were initially assessed according to World Health Organization (WHO) criteria. Samples were washed twice with Ham’s. Each sample was divided into two portions, a control and the other processed for density gradient centrifugation (DGC). Each portion was assessed for CMA3 staining by both the slide and flow cytometry methods. Coefficients of correlation and student t-test were carried out using the Statistical Package for the Social Studies (SPSS 11.5). Results Detection of CMA3 staining was more appropriate with fluorescence detector 3 (FL-3) rather than fluorescence detector 2 (FL-2) in the evaluation of protamine deficiency to exclude M540 bodies. Conclusion This study, for the first time, provides the basis for assessment of CMA3 staining for flow cytometry. However, since the maximum excitation for CMA3 is not covered by the 488 nm laser, we recommend further experimentation using a flow cytometer with optimal excitation. |
| first_indexed | 2024-12-12T23:42:17Z |
| format | Article |
| id | doaj.art-08ea4b2b63924cc79fef97659475d115 |
| institution | Directory Open Access Journal |
| issn | 2008-076X 2008-0778 |
| language | English |
| last_indexed | 2024-12-12T23:42:17Z |
| publishDate | 2011-10-01 |
| publisher | Royan Institute (ACECR), Tehran |
| record_format | Article |
| series | International Journal of Fertility and Sterility |
| spelling | doaj.art-08ea4b2b63924cc79fef97659475d1152022-12-22T00:07:04ZengRoyan Institute (ACECR), TehranInternational Journal of Fertility and Sterility2008-076X2008-07782011-10-015312813345096Flow Cytometry: A Novel Approach for Indirect Assessment of Protamine Deficiency by CMA3 Staining, Taking into Account the Presence of M540 or Apoptotic BodiesZohreh Fathi0Marziyeh Tavalaee1Abbas Kiani2Mohammad Reza Deemeh3Mehrdad Modaresi4Mohammad Hossein Nasr-Esfahani5Department of Reproduction and Development, Reproductive Biomedicine Center, Royan Institute for Animal Biotechnology, ACECR, Isfahan, Iran;Payame Noor University, Isfahan, IranDepartment of Reproduction and Development, Reproductive Biomedicine Center, Royan Institute for Animal Biotechnology, ACECR, Isfahan, IranDepartment of Reproduction and Development, Reproductive Biomedicine Center, Royan Institute for Animal Biotechnology, ACECR, Isfahan, IranDepartment of Reproduction and Development, Reproductive Biomedicine Center, Royan Institute for Animal Biotechnology, ACECR, Isfahan, Iran;Isfahan Fertility and Infertility Center, Isfahan, Iran4Islamic Azad University-Khorasgan Branch, Isfahan, IranDepartment of Reproduction and Development, Reproductive Biomedicine Center, Royan Institute for Animal Biotechnology, ACECR, Isfahan, Iran;Isfahan Fertility and Infertility Center, Isfahan, Iran;5Department of EmbryoloBackground Chromomycin A3 (CMA3) staining, either by the slide method or fluorescence microscopy, is widely used for indirect assessment of protamine deficiency in a semen sample. Flow cytometry is the most suitable tool to improve assessment accuracy, both in terms of statistical analysis and for prevention of observer variation. This study provides a simple procedure to account for merocyanine 540 (M540) or apoptotic bodies, which result in underestimation of the percentage of CMA3 positivity, by using propidium iodide (PI) staining. Therefore, this study aims to evaluate the percentage of CMA3 by PI staining to exclude M540 bodies that prevent underestimation of CMA3 staining. Materials and Methods This study is an experimental study. Semen samples collected from 104 infertile men who referred to the Andrology Unit of the Isfahan Fertility and Infertility Center were initially assessed according to World Health Organization (WHO) criteria. Samples were washed twice with Ham’s. Each sample was divided into two portions, a control and the other processed for density gradient centrifugation (DGC). Each portion was assessed for CMA3 staining by both the slide and flow cytometry methods. Coefficients of correlation and student t-test were carried out using the Statistical Package for the Social Studies (SPSS 11.5). Results Detection of CMA3 staining was more appropriate with fluorescence detector 3 (FL-3) rather than fluorescence detector 2 (FL-2) in the evaluation of protamine deficiency to exclude M540 bodies. Conclusion This study, for the first time, provides the basis for assessment of CMA3 staining for flow cytometry. However, since the maximum excitation for CMA3 is not covered by the 488 nm laser, we recommend further experimentation using a flow cytometer with optimal excitation.http://www.ijfs.ir/article_45096_6f1f745f24924b7b83cf544b2525341a.pdfflow cytometryspermprotaminemerocyanine |
| spellingShingle | Zohreh Fathi Marziyeh Tavalaee Abbas Kiani Mohammad Reza Deemeh Mehrdad Modaresi Mohammad Hossein Nasr-Esfahani Flow Cytometry: A Novel Approach for Indirect Assessment of Protamine Deficiency by CMA3 Staining, Taking into Account the Presence of M540 or Apoptotic Bodies International Journal of Fertility and Sterility flow cytometry sperm protamine merocyanine |
| title | Flow Cytometry: A Novel Approach for Indirect Assessment of Protamine Deficiency by CMA3 Staining, Taking into Account the Presence of M540 or Apoptotic Bodies |
| title_full | Flow Cytometry: A Novel Approach for Indirect Assessment of Protamine Deficiency by CMA3 Staining, Taking into Account the Presence of M540 or Apoptotic Bodies |
| title_fullStr | Flow Cytometry: A Novel Approach for Indirect Assessment of Protamine Deficiency by CMA3 Staining, Taking into Account the Presence of M540 or Apoptotic Bodies |
| title_full_unstemmed | Flow Cytometry: A Novel Approach for Indirect Assessment of Protamine Deficiency by CMA3 Staining, Taking into Account the Presence of M540 or Apoptotic Bodies |
| title_short | Flow Cytometry: A Novel Approach for Indirect Assessment of Protamine Deficiency by CMA3 Staining, Taking into Account the Presence of M540 or Apoptotic Bodies |
| title_sort | flow cytometry a novel approach for indirect assessment of protamine deficiency by cma3 staining taking into account the presence of m540 or apoptotic bodies |
| topic | flow cytometry sperm protamine merocyanine |
| url | http://www.ijfs.ir/article_45096_6f1f745f24924b7b83cf544b2525341a.pdf |
| work_keys_str_mv | AT zohrehfathi flowcytometryanovelapproachforindirectassessmentofprotaminedeficiencybycma3stainingtakingintoaccountthepresenceofm540orapoptoticbodies AT marziyehtavalaee flowcytometryanovelapproachforindirectassessmentofprotaminedeficiencybycma3stainingtakingintoaccountthepresenceofm540orapoptoticbodies AT abbaskiani flowcytometryanovelapproachforindirectassessmentofprotaminedeficiencybycma3stainingtakingintoaccountthepresenceofm540orapoptoticbodies AT mohammadrezadeemeh flowcytometryanovelapproachforindirectassessmentofprotaminedeficiencybycma3stainingtakingintoaccountthepresenceofm540orapoptoticbodies AT mehrdadmodaresi flowcytometryanovelapproachforindirectassessmentofprotaminedeficiencybycma3stainingtakingintoaccountthepresenceofm540orapoptoticbodies AT mohammadhosseinnasresfahani flowcytometryanovelapproachforindirectassessmentofprotaminedeficiencybycma3stainingtakingintoaccountthepresenceofm540orapoptoticbodies |